The Role of STAT3 in Non-Small Cell Lung Cancer

por Harada, Daijiro, Takigawa, Nagio, Kiura, Katsuyuki
Publicado 2014

Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer

por Isozaki, Hideko, Takigawa, Nagio, Kiura, Katsuyuki
Publicado en Cancers (Basel) (2015)

Managing Lung Cancer with Comorbid Interstitial Pneumonia

por Ichihara, Eiki, Miyahara, Nobuaki, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado en Intern Med (2019)

Rapid on-site evaluation with BIOEVALUATOR(®) during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing pulmonary and mediastinal diseases

por Minami, Daisuke, Takigawa, Nagio, Inoue, Hirofumi, Hotta, Katsuyuki, Tanimoto, Mitsune, Kiura, Katsuyuki
Publicado 2014

Correlation of plasma crizotinib trough concentration with adverse events in patients with anaplastic lymphoma kinase positive non-small-cell lung cancer

por Kurata, Yasuko, Miyauchi, Narumi, Suno, Manabu, Ito, Takahiro, Sendo, Toshiaki, Kiura, Katsuyuki
Publicado en J Pharm Health Care Sci (2015)

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

por Watanabe, Hiromi, Ichihara, Eiki, Kano, Hirohisa, Ninomiya, Kiichiro, Tanimoto, Mitsune, Kiura, Katsuyuki
Publicado en Intern Med (2017)

Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance...

por Makimoto, Go, Ohashi, Kadoaki, Senoo, Satoru, Hotta, Katsuyuki, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado en Intern Med (2019)

Demand for weekend outpatient chemotherapy among patients with cancer in Japan

por Katayama, Hideki, Tabata, Masahiro, Kubo, Toshio, Kiura, Katsuyuki, Matsuoka, Junji, Maeda, Yoshinobu
Publicado en Support Care Cancer (2020)

Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?

por Sato, Hiroki, Soh, Junichi, Hotta, Katsuyuki, Katsui, Kuniaki, Kanazawa, Susumu, Kiura, Katsuyuki, Toyooka, Shinichi
Publicado en Ann Thorac Cardiovasc Surg (2018)

Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results

por Oze, Isao, Hotta, Katsuyuki, Kiura, Katsuyuki, Ochi, Nobuaki, Takigawa, Nagio, Fujiwara, Yoshiro, Tabata, Masahiro, Tanimoto, Mitsune
Publicado 2009

Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review

por Hotta, Katsuyuki, Kiura, Katsuyuki, Fujiwara, Yoshiro, Takigawa, Nagio, Hisamoto, Akiko, Ichihara, Eiki, Tabata, Masahiro, Tanimoto, Mitsune
Publicado 2011

Variant angina pectoris associated with FOLFOX4 therapy

por Yamane, Hiromichi, Matsubara, Minoru, Umemura, Shigeki, Suwaki, Toshimitsu, Kamei, Haruhito, Takigawa, Nagio, Kiura, Katsuyuki, Tanimoto, Mitsune
Publicado 2011

Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis

por Toyooka, Shinichi, Kiura, Katsuyuki, Takemoto, Mitsuhiro, Oto, Takahiro, Takigawa, Nagio, Fujiwara, Toshiyoshi, Miyoshi, Shinichiro, Date, Hiroshi
Publicado 2012

Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis

por Toyooka, Shinichi, Kiura, Katsuyuki, Shien, Kazuhiko, Katsui, Kuniaki, Hotta, Katsuyuki, Kanazawa, Susumu, Date, Hiroshi, Miyoshi, Shinichiro
Publicado 2012

A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages

por Watanabe, Hiromi, Ohashi, Kadoaki, Nishii, Kazuya, Seike, Keisuke, Makimoto, Go, Hotta, Katsuyuki, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado en Intern Med (2019)

Granulation Tissue-induced Pseudo-relapse During Nivolumab Treatment in Advanced Non-small Cell Lung Cancer

por ANDO, CHIHIRO, ICHIHARA, EIKI, KANO, HIROHISA, IWAMOTO, YOSHITAKA, HIRABAE, ATSUKO, NAKASUKA, TAKAMASA, MAEDA, YOSHINOBU, KIURA, KATSUYUKI
Publicado en In Vivo (2019)

An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report

por Yamane, Hiromichi, Kinugawa, Masahide, Umemura, Shigeki, Shiote, Yasuhiro, Kudo, Kenichiro, Suwaki, Toshimitsu, Kamei, Haruhito, Takigawa, Nagio, Kiura, Katsuyuki
Publicado 2011

Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

por Yamane, Hiromichi, Ochi, Nobuaki, Yasugi, Masayuki, Tabayashi, Takayuki, Yamagishi, Tomoko, Monobe, Yasumasa, Hisamoto, Akiko, Kiura, Katsuyuki, Takigawa, Nagio
Publicado 2013

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer

por Ichihara, Eiki, Hotta, Katsuyuki, Kubo, Toshio, Higashionna, Tsukasa, Ninomiya, Kiichiro, Ohashi, Kadoaki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado en Oncotarget (2018)

A case of axillary lymphadenitis caused by Mycobacterium intracellulare in an immunocompetent patient

por Itano, Junko, Ohashi, Kadoaki, Senoo, Satoru, Oda, Naohiro, Nishii, Kazuya, Taniguchi, Akihiko, Miyahara, Nobuaki, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado en Respir Med Case Rep (2019)